Tracing Oncogene Rearrangements in the Mutational History of Lung Adenocarcinoma

Signatures of mutational processes in human cancer

Initiative, A. P. C. G., Alexandrov, L. B., ICGC Breast Cancer Consortium, ICGC MMML-Seq Consortium, PedBrain, I., Nik-Zainal, S., Wedge, D. C., Aparicio, S. A. J. R., Behjati, S., Biankin, A. V., et al. (2013) · Nature · doi:10.1038/nature12477 · Cited by 9,660 · see citing works

Gefitinib or Carboplatin–Paclitaxel in Pulmonary Adenocarcinoma

Mok, T. S., Wu, Y.-L., Thongprasert, S., Yang, C.-H., Chu, D.-T., Saijo, N., Sunpaweravong, P., Han, B., Margono, B., Ichinose, Y., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0810699 · Cited by 8,261 · see citing works

Comprehensive molecular profiling of lung adenocarcinoma

The Cancer Genome Atlas Research Network (2014) · Nature · doi:10.1038/nature13385 · Cited by 5,732 · see citing works

Identification of the transforming EML4–ALK fusion gene in non-small-cell lung cancer

Soda, M., Choi, Y. L., Enomoto, M., Takada, S., Yamashita, Y., Ishikawa, S., Fujiwara, S.-I., Watanabe, H., Kurashina, K., Hatanaka, H., et al. (2007) · Nature · doi:10.1038/nature05945 · Cited by 5,439 · see citing works

The biology and management of non-small cell lung cancer

Herbst, R. S., Morgensztern, D., & Boshoff, C. (2018) · Nature · doi:10.1038/nature25183 · Cited by 4,891 · see citing works

Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples

Cibulskis, K., Lawrence, M. S., Carter, S. L., Sivachenko, A., Jaffe, D. B., Sougnez, C. L., Gabriel, S., Meyerson, M. M., Lander, E. S., & Getz, G. A. (2013) · Nature Biotechnology · doi:10.1038/nbt.2514 · Cited by 4,838 · see citing works

VarScan 2: Somatic mutation and copy number alteration discovery in cancer by exome sequencingPreprint

Koboldt, D. C., Zhang, Q., Larson, D. E., Shen, D., McLellan, M. D., Lin, L., Miller, C. A., Mardis, E. R., Ding, L., & Wilson, R. K. (2012) · Genome Research · doi:10.1101/gr.129684.111 · Cited by 4,822 · see citing works

<i>MET</i> Amplification Leads to Gefitinib Resistance in Lung Cancer by Activating ERBB3 Signaling

Engelman, J. A., Zejnullahu, K., Mitsudomi, T., Song, Y., Hyland, C., Park, J. O., Lindeman, N., Gale, C.-M., Zhao, X., Christensen, J., et al. (2007) · Science · doi:10.1126/science.1141478 · Cited by 4,496 · see citing works

The cancer genome

Stratton, M. R., Campbell, P. J., & Futreal, P. A. (2009) · Nature · doi:10.1038/nature07943 · Cited by 3,458 · see citing works

Crizotinib versus Chemotherapy in Advanced <i>ALK</i> -Positive Lung Cancer

Shaw, A. T., Kim, D.-W., Nakagawa, K., Seto, T., Crinó, L., Ahn, M.-J., De Pas, T., Besse, B., Solomon, B. J., Blackhall, F., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1214886 · Cited by 3,381 · see citing works

Mutational landscape of metastatic cancer revealed from prospective clinical sequencing of 10,000 patients

Zehir, A., Benayed, R., Shah, R. H., Syed, A., Middha, S., Kim, H. R., Srinivasan, P., Gao, J., Chakravarty, D., Devlin, S. M., et al. (2017) · Nature Medicine · doi:10.1038/nm.4333 · Cited by 3,380 · see citing works

OncoKB: A Precision Oncology Knowledge Base

Chakravarty, D., Gao, J., Phillips, S. M., Kundra, R., Zhang, H., Wang, J., Rudolph, J. E., Yaeger, R. D., Soumerai, T. E., Nissan, M. H., et al. (2017) · JCO Precision Oncology · doi:10.1200/po.17.00011 · Cited by 2,735 · see citing works

Massive genomic rearrangement acquired in a single catastrophic event during cancer development

Stephens, P. J., Greenman, C. D., Fu, B., Yang, F., Bignell, G. R., Mudie, L. J., Pleasance, E. D., Lau, K. W., Beare, D., Stebbings, L. A., et al. (2011) · Cell · doi:10.1016/j.cell.2010.11.055 · Cited by 2,414 · see citing works

DELLY: structural variant discovery by integrated paired-end and split-read analysis

Rausch, T., Zichner, T., Schlattl, A., Stütz, A. M., Beneš, V., & Korbel, J. O. (2012) · Bioinformatics · doi:10.1093/bioinformatics/bts378 · Cited by 2,384 · see citing works

Tracking the Evolution of Non–Small-Cell Lung Cancer

Jamal-Hanjani, M., Wilson, G. A., McGranahan, N., Birkbak, N. J., Watkins, T. B. K., Veeriah, S., Shafi, S., Johnson, D. H., Mitter, R., Rosenthal, R., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1616288 · Cited by 2,349 · see citing works

Crizotinib in <i>ROS1</i>-Rearranged Non–Small-Cell Lung Cancer

Shaw, A. T., Ou, S.-H. I., Bang, Y.-J., Camidge, D. R., Solomon, B. J., Salgia, R., Riely, G. J., Varella-Garcia, M., Shapiro, G. I., Costa, D. B., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1406766 · Cited by 1,964 · see citing works

Analysis of lung tumor initiation and progression using conditional expression of oncogenic K-rasPreprint

Jackson, E. L., Willis, N. A., Mercer, K. L., Bronson, R. T., Crowley, D. G., Montoya, R., Jacks, T., & Tuveson, D. A. (2001) · Genes & Development · doi:10.1101/gad.943001 · Cited by 1,877 · see citing works

Mapping the Hallmarks of Lung Adenocarcinoma with Massively Parallel Sequencing

Imielinski, M., Berger, A. H., Hammerman, P. S., Hernandez, B., Pugh, T. J., Hodis, E., Cho, J., Suh, J., Capelletti, M., Sivachenko, A., et al. (2012) · Cell · doi:10.1016/j.cell.2012.08.029 · Cited by 1,789 · see citing works

Lung cancer in never smokers — a different disease

Sun, S., Schiller, J. H., & Gazdar, A. F. (2007) · Nature reviews. Cancer · doi:10.1038/nrc2190 · Cited by 1,601 · see citing works

Strelka: accurate somatic small-variant calling from sequenced tumor–normal sample pairs

Saunders, C. T., Wong, W. S. W., Swamy, S., Becq, J., Murray, L. J., & Cheetham, R. K. (2012) · Bioinformatics · doi:10.1093/bioinformatics/bts271 · Cited by 1,589 · see citing works

Integrated genomic and molecular characterization of cervical cancer

Burk, R. D., Chen, Z., Cf, S., Tarvin, K., Carvalho, A. L., Scapulatempo‐Neto, C., Silveira, H. C. S., Fregnani, J. H. T. G., Creighton, C. J., Anderson, M. L., et al. (2017) · Nature · doi:10.1038/nature21386 · Cited by 1,575 · see citing works

The Life History of 21 Breast Cancers

Nik-Zainal, S., Van Loo, P., Wedge, D. C., Alexandrov, L. B., Greenman, C. D., Lau, K. W., Raine, K., Jones, D., Marshall, J., Ramakrishna, M., et al. (2012) · Cell · doi:10.1016/j.cell.2012.04.023 · Cited by 1,443 · see citing works

The impact of translocations and gene fusions on cancer causation

Mitelman, F., Johansson, B., & Mertens, F. (2007) · Nature Reviews Cancer · doi:10.1038/nrc2091 · Cited by 1,400 · see citing works

Mechanisms of Acquired Crizotinib Resistance in ALK-Rearranged Lung Cancers

Katayama, R., Shaw, A. T., Khan, T. M., Mino-Kenudson, M. A., Solomon, B., Halmos, B., Jessop, N. A., Wain, J. C., Yeo, A. T., Benes, C. H., et al. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3003316 · Cited by 1,316 · see citing works

Punctuated Evolution of Prostate Cancer Genomes

Baca, S. C., Prandi, D., Lawrence, M. S., Mosquera, J. M., Romanel, A., Drier, Y., Park, K., Kitabayashi, N., MacDonald, T. Y., Ghandi, M., et al. (2013) · Cell · doi:10.1016/j.cell.2013.03.021 · Cited by 1,300 · see citing works

Chromothripsis from DNA damage in micronuclei

Zhang, C., Spektor, A., Cornils, H., Francis, J. M., Jackson, E. K., Liu, S., Meyerson, M. M., & Pellman, D. S. (2015) · Nature · doi:10.1038/nature14493 · Cited by 1,153 · see citing works

Genomic Landscape of Non-Small Cell Lung Cancer in Smokers and Never-Smokers

Govindan, R., Ding, L., Griffith, M., Subramanian, J., Dees, N. D., Kanchi, K., Maher, C. A., Fulton, R. S., Fulton, L., Wallis, J. W., et al. (2012) · Cell · doi:10.1016/j.cell.2012.08.024 · Cited by 1,144 · see citing works

Stem cell divisions, somatic mutations, cancer etiology, and cancer prevention

Tomasetti, C., Li, L., & Vogelstein, B. (2017) · Science · doi:10.1126/science.aaf9011 · Cited by 1,113 · see citing works

Clock-like mutational processes in human somatic cells

Alexandrov, L. B., Jones, P. H., Wedge, D. C., Sale, J. E., Campbell, P. J., Nik‐Zainal, S., & Stratton, M. R. (2015) · Nature Genetics · doi:10.1038/ng.3441 · Cited by 1,038 · see citing works

Tissue-specific mutation accumulation in human adult stem cells during life

Blokzijl, F., de Ligt, J., Jager, M., Sasselli, V., Roerink, S., Sasaki, N., Huch, M., Boymans, S., Kuijk, E., Prins, P., et al. (2016) · Nature · doi:10.1038/nature19768 · Cited by 935 · see citing works

Genome sequencing of pediatric medulloblastoma links catastrophic DNA rearrangements with TP53 mutations

Rausch, T., Jones, D. T. W., Zapatka, M., Stütz, A. M., Zichner, T., Weischenfeldt, J., Jäger, N., Remke, M., Shih, D., Northcott, P. A., et al. (2012) · Cell · doi:10.1016/j.cell.2011.12.013 · Cited by 865 · see citing works

Extrachromosomal oncogene amplification drives tumour evolution and genetic heterogeneity

Turner, K. M., Deshpande, V., Beyter, D., Koga, T., Rusert, J. M., Lee, C., Li, B., Arden, K. C., Ren, B., Nathanson, D. A., et al. (2017) · Nature · doi:10.1038/nature21356 · Cited by 852 · see citing works

Mechanisms underlying mutational signatures in human cancers

Helleday, T., Eshtad, S., & Nik‐Zainal, S. (2014) · Nature Reviews Genetics · doi:10.1038/nrg3729 · Cited by 841 · see citing works

Sequenza: allele-specific copy number and mutation profiles from tumor sequencing data

Favero, F., Joshi, T., Marquard, A. M., Birkbak, N. J., Krzystanek, M., Li, Q., Szállási, Z., & Eklund, A. C. (2014) · Annals of Oncology · doi:10.1093/annonc/mdu479 · Cited by 804 · see citing works

Assessing Tumor-infiltrating Lymphocytes in Solid Tumors: A Practical Review for Pathologists and Proposal for a Standardized Method From the International Immunooncology Biomarkers Working Group: Part 1: Assessing the Host Immune Response, TILs in Invasive Breast Carcinoma and Ductal Carcinoma In Situ, Metastatic Tumor Deposits and Areas for Further Research

Hendry, S. A., Salgado, R., Gevaert, T., Russell, P. A., John, T., Thapa, B., Christie, M., de Vijver, K. K. V., Estrada, M. V., Ericsson, P. I. G., et al. (2017) · Advances in Anatomic Pathology · doi:10.1097/pap.0000000000000162 · Cited by 707 · see citing works

Chromothripsis and Kataegis Induced by Telomere Crisis

Maciejowski, J., Li, Y., Bosco, N., Campbell, P. J., & de Lange, T. (2015) · Cell · doi:10.1016/j.cell.2015.11.054 · Cited by 675 · see citing works

Age-related remodelling of oesophageal epithelia by mutated cancer drivers

Yokoyama, A., Kakiuchi, N., Yoshizato, T., Nannya, Y., Suzuki, H., Takeuchi, Y., Shiozawa, Y., Sato, Y., Aoki, K., Kim, S. K., et al. (2019) · Nature · doi:10.1038/s41586-018-0811-x · Cited by 628 · see citing works

Androgen-induced TOP2B-mediated double-strand breaks and prostate cancer gene rearrangements

Haffner, M. C., Aryee, M. J., Toubaji, A., Esopi, D., Albadine, R., Gürel, B., Isaacs, W. B., Bova, G. S., Liu, W., Xu, J., et al. (2010) · Nature Genetics · doi:10.1038/ng.613 · Cited by 606 · see citing works

The transcriptional landscape and mutational profile of lung adenocarcinomaPreprint

Seo, J., Ju, Y. S., Lee, W., Shin, J.-Y., Lee, J. J.-K., Bleazard, T., Lee, J., Jung, Y. J., Kim, J. O., Shin, J.-Y., et al. (2012) · Genome Research · doi:10.1101/gr.145144.112 · Cited by 589 · see citing works

Clonal History and Genetic Predictors of Transformation Into Small-Cell Carcinomas From Lung Adenocarcinomas

Lee, J. J.-K., Lee, J., Kim, S., Kim, S., Youk, J., Park, S., An, Y., Keam, B., Kim, D., Heo, D. S., et al. (2017) · Journal of Clinical Oncology · doi:10.1200/jco.2016.71.9096 · Cited by 506 · see citing works

Timing the Landmark Events in the Evolution of Clear Cell Renal Cell Cancer: TRACERx Renal

Mitchell, T. J., Turajlic, S., Rowan, A., Nicol, D. L., Farmery, J. H. R., O’Brien, T., Martincorena, I., Tarpey, P. S., Angelopoulos, N., Yates, L. R., et al. (2018) · Cell · doi:10.1016/j.cell.2018.02.020 · Cited by 502 · see citing works

A transforming KIF5B and RET gene fusion in lung adenocarcinoma revealed from whole-genome and transcriptome sequencingPreprint

Ju, Y. S., Lee, W., Shin, J.-Y., Lee, S., Bleazard, T., Won, J., Kim, Y. T., Kim, J., Kang, J. H., & Seo, J. (2011) · Genome Research · doi:10.1101/gr.133645.111 · Cited by 486 · see citing works

The impact of human EGFR kinase domain mutations on lung tumorigenesis and in vivo sensitivity to EGFR-targeted therapies

Ji, H., Li, D., Chen, L., Shimamura, T., Kobayashi, S., McNamara, K., Mahmood, U., Mitchell, A., Sun, Y., Al-Hashem, R., et al. (2006) · Cancer Cell · doi:10.1016/j.ccr.2006.04.022 · Cited by 462 · see citing works

Chromosome Mis-segregation Generates Cell-Cycle-Arrested Cells with Complex Karyotypes that Are Eliminated by the Immune System

Santaguida, S., Richardson, A., Iyer, D., M’Saad, O., Zasadil, L. M., Knouse, K. A., Wong, Y. L., Rhind, N., Desai, A. B., & Amon, A. (2017) · Developmental Cell · doi:10.1016/j.devcel.2017.05.022 · Cited by 355 · see citing works

Oncogenic ERBB3 mutations in human cancers.

Jaiswal, B. S., Kljavin, N. M., Stawiski, E. W., Chan, E., Parikh, C., Durinck, S., Chaudhuri, S., Pujara, K., Guillory, J., Edgar, K. A., et al. (2013) · Cancer Cell · doi:10.1016/j.ccr.2013.04.012 · Cited by 350 · see citing works

Characterization of Uterine Leiomyomas by Whole-Genome Sequencing

Mehine, M. M., Kaasinen, E., Mäkinen, N., Katainen, R., Kämpjärvi, K., Pitkänen, E., Heinonen, H.-R., Bützow, R. C., Kilpivaara, O., Kuosmanen, A., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1302736 · Cited by 346 · see citing works

Pan-cancer analysis of whole genomesPreprint

Campbell, P., Getz, G., Stuart, J. M., Korbel, J., & Stein, L. D. (2017) · bioRxiv · doi:10.1101/162784 · Cited by 343 · see citing works

The genomic landscape of balanced cytogenetic abnormalities associated with human congenital anomalies

Redin, C., Brand, H., Collins, R. L., Kammin, T., Mitchell, E., Hodge, J. C., Hanscom, C., Pillalamarri, V., Seabra, C. M., Abbott, M.-A., et al. (2017) · Nature Genetics · doi:10.1038/ng.3720 · Cited by 334 · see citing works

Chromothripsis as a mechanism driving complex de novo structural rearrangements in the germline†

Kloosterman, W. P., Guryev, V., van Roosmalen, M. J., Duran, K. J., de Bruijn, E., Bakker, S. C. M., Letteboer, T. G. W., van Nesselrooij, B. P. M., Hochstenbach, R., Poot, M., et al. (2011) · Human Molecular Genetics · doi:10.1093/hmg/ddr073 · Cited by 320 · see citing works

Inhibiting WEE1 Selectively Kills Histone H3K36me3-Deficient Cancers by dNTP Starvation

Pfister, S. X., Markkanen, E., Jiang, Y., Sarkar, S., Woodcock, M., Orlando, G., Mavrommati, I., Pai, C., Zalmas, L., Drobnitzky, N., et al. (2015) · Cancer Cell · doi:10.1016/j.ccell.2015.09.015 · Cited by 300 · see citing works

Tyrosine kinase gene rearrangements in epithelial malignancies

Shaw, A. T., Hsu, P. P., Awad, M. M., & Engelman, J. A. (2013) · Nature reviews. Cancer · doi:10.1038/nrc3612 · Cited by 291 · see citing works

Dual Chromatin and Cytoskeletal Remodeling by SETD2

Park, I. Y., Powell, R. T., Tripathi, D. N., Dere, R., Ho, T. H., Blasius, T. L., Chiang, Y.-C., Davis, I. J., Fahey, C. C., Hacker, K. E., et al. (2016) · Cell · doi:10.1016/j.cell.2016.07.005 · Cited by 268 · see citing works

SETD2 is required for DNA double-strand break repair and activation of the p53-mediated checkpoint

Carvalho, S., Vítor, A. C., Sridhara, S. R. C., Martins, F. B., Raposo, A. C., Desterro, J. M. P., Ferreira, J. A., & de Almeida, S. F. (2014) · eLife · doi:10.7554/elife.02482 · Cited by 266 · see citing works

Complex reorganization and predominant non-homologous repair following chromosomal breakage in karyotypically balanced germline rearrangements and transgenic integration

Chiang, C., Jacobsen, J. C., Ernst, C., Hanscom, C., Heilbut, A. M., Blumenthal, I., Mills, R. E., Kirby, A. W., Lindgren, A. M., Rudiger, S. R., et al. (2012) · Nature Genetics · doi:10.1038/ng.2202 · Cited by 252 · see citing works

Chromothripsis and beyond: rapid genome evolution from complex chromosomal rearrangementsPreprint

Zhang, C.-Z., Leibowitz, M. L., & Pellman, D. (2013) · Genes & Development · doi:10.1101/gad.229559.113 · Cited by 241 · see citing works

The Architecture and Evolution of Cancer Neochromosomes

Garsed, D. W., Marshall, O. J., Corbin, V. D. A., Hsu, A., Di Stefano, L., Schröder, J., Li, J., Feng, Z.-P., Kim, B. W., Kowarsky, M., et al. (2014) · Cancer Cell · doi:10.1016/j.ccell.2014.09.010 · Cited by 194 · see citing works

p53: Guardian of ploidy

Aylon, Y., & Oren, M. (2011) · Molecular Oncology · doi:10.1016/j.molonc.2011.07.007 · Cited by 190 · see citing works

Chronic Cigarette Smoke-Induced Epigenomic Changes Precede Sensitization of Bronchial Epithelial Cells to Single-Step Transformation by KRAS Mutations

Vaz, M. J., Hwang, S. Y., Kagiampakis, I., Phallen, J. A., Patil, A., O’Hagan, H. M., Murphy, L. M., Zahnow, C. A., Gabrielson, E., Velculescu, V. E., et al. (2017) · Cancer Cell · doi:10.1016/j.ccell.2017.08.006 · Cited by 186 · see citing works

Rearrangement bursts generate canonical gene fusions in bone and soft tissue tumors

Anderson, N. D., de Borja, R., Young, M. D., Fuligni, F., Rosic, A., Roberts, N. D., Hajjar, S., Layeghifard, M., Novokmet, A., Kowalski, P. E., et al. (2018) · Science · doi:10.1126/science.aam8419 · Cited by 184 · see citing works

Break-Induced Replication Is a Source of Mutation Clusters Underlying Kataegis

Sakofsky, C. J., Roberts, S. A., Malc, E. P., Mieczkowski, P. A., Resnick, M. A., Gordenin, D. A., & Malkova, A. (2014) · Cell Reports · doi:10.1016/j.celrep.2014.04.053 · Cited by 177 · see citing works

A Functional Landscape of Resistance to ALK Inhibition in Lung Cancer

Wilson, F. H., Johannessen, C. M., Piccioni, F., Tamayo, P., Kim, J. W., Allen, E. M. V., Corsello, S. M., Capelletti, M., Calles, A., Butaney, M., et al. (2015) · Cancer Cell · doi:10.1016/j.ccell.2015.02.005 · Cited by 171 · see citing works

Clinicopathologic analysis of programmed cell death-1 and programmed cell death-ligand 1 and 2 expressions in pulmonary adenocarcinoma: comparison with histology and driver oncogenic alteration status

Koh, J., Go, H., Keam, B., Kim, M., Nam, S. J., Kim, T. M., Lee, S., Min, H. S., Kim, Y. T., Kim, D., et al. (2015) · Modern Pathology · doi:10.1038/modpathol.2015.63 · Cited by 160 · see citing works

Multi-organ Mapping of Cancer Risk

Zhu, L., Finkelstein, D., Gao, C., Shi, L. G., Wang, Y., Lopez-Terrada, D. H., Wang, K. S., Utley, S., Pounds, S. B., Neale, G. A. M., et al. (2016) · Cell · doi:10.1016/j.cell.2016.07.045 · Cited by 154 · see citing works

Whole-genome sequencing reveals genomic signatures associated with the inflammatory microenvironments in Chinese NSCLC patients

Wang, C., Yin, R. H., Dai, J., Gu, Y., Cui, S., Ma, H., Zhang, Z., Huang, J., Qin, N., Jiang, T., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-04492-2 · Cited by 115 · see citing works

Frequent alterations in cytoskeleton remodelling genes in primary and metastatic lung adenocarcinomas

Wu, K., Zhang, X., Li, F., Xiao, D., Hou, Y., Zhu, S., Liu, D., Ye, X., Ye, M., Yang, J., et al. (2015) · Nature Communications · doi:10.1038/ncomms10131 · Cited by 109 · see citing works

Mutalisk: a web-based somatic MUTation AnaLyIS toolKit for genomic, transcriptional and epigenomic signatures

Lee, J., Lee, A., Lee, J., Park, J., Kwon, Y., Park, S., Chun, H., Ju, Y., & Hong, D. (2018) · Nucleic Acids Res. · doi:10.1093/nar/gky406 · Cited by 84 · see citing works

Complex chromosomal rearrangements by single catastrophic pathogenesis in NUT midline carcinoma

Lee, J. J.-K., Louzada, S., An, Y., Kim, S. Y., Kim, S., Youk, J., Park, S., Koo, S. H., Keam, B., Jeon, Y. K., et al. (2016) · Annals of Oncology · doi:10.1093/annonc/mdw686 · Cited by 78 · see citing works

The evolutionary history of 2,658 cancersPreprint

Gerstung, M., Jolly, C., Leshchiner, I., Dentro, S. C., González, S., Rosebrock, D., Mitchell, T. J., Rubanova, Y., Anur, P., Yu, K., et al. (2017) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/161562 · Cited by 51 · see citing works

Development of Lung Adenocarcinomas with Exclusive Dependence on Oncogene Fusions

Saito, M., Shimada, Y., Shiraishi, K., Sakamoto, H., Tsuta, K., Totsuka, H., Chiku, S., Ichikawa, H., Kato, M., WATANABE, S.-I. I., et al. (2015) · Cancer Research · doi:10.1158/0008-5472.can-14-3282 · Cited by 43 · see citing works

Co-occurring genomic alterations in non-small-cell lung cancer biology and therapy

Skoulidis, F., & Heymach, J. V. (2019) · Nature Reviews Cancer · doi:10.1038/s41568-019-0179-8 · Cited by 1,019 · see citing works

Lung adenocarcinoma promotion by air pollutants

Hill, W., Lim, E. L., Weeden, C. E., Lee, C., Augustine, M., Chen, K., Kuan, F.-C., Marongiu, F., Evans, E. J., Moore, D. A., et al. (2023) · Nature · doi:10.1038/s41586-023-05874-3 · Cited by 808 · see citing works

Characterizing genetic intra-tumor heterogeneity across 2,658 human cancer genomes

Dentro, S. C., Leshchiner, I., Haase, K., Tarabichi, M., Wintersinger, J., Deshwar, A. G., Yu, K., Rubanova, Y., Macintyre, G., Demeulemeester, J., et al. (2021) · Cell · doi:10.1016/j.cell.2021.03.009 · Cited by 533 · see citing works

Tobacco smoking and somatic mutations in human bronchial epithelium

Yoshida, K., Gowers, K. H. C., Lee-Six, H., Chandrasekharan, D. P., Coorens, T. H. H., Maughan, E. F., Beal, K. M., Menzies, A. H., Millar, F. R., Anderson, E. L., et al. (2020) · Nature · doi:10.1038/s41586-020-1961-1 · Cited by 532 · see citing works

Histone lysine methyltransferases in biology and disease

Husmann, D., & Gozani, O. (2019) · Nature Structural & Molecular Biology · doi:10.1038/s41594-019-0298-7 · Cited by 469 · see citing works

Mechanisms generating cancer genome complexity from a single cell division error

Umbreit, N. T., Zhang, C.-Z., Lynch, L. D., Blaine, L. J., Cheng, A. M., Tourdot, R., Sun, L., Almubarak, H. F., Judge, K., Mitchell, T. J., et al. (2020) · Science · doi:10.1126/science.aba0712 · Cited by 439 · see citing works

Tumor initiation and early tumorigenesis: molecular mechanisms and interventional targets

Zhang, S., Xiao, X., Yi, Y., Wang, X., Zhu, L., Shen, Y., Lin, D., & Wu, C. H. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01848-7 · Cited by 440 · see citing works

Distinct Classes of Complex Structural Variation Uncovered across Thousands of Cancer Genome Graphs

Hadi, K., Yao, X., Behr, J. M., Deshpande, A. S., Xanthopoulakis, C., Tian, H., Kudman, S., Rosiene, J. A., Darmofal, M., DeRose, J., et al. (2020) · Cell · doi:10.1016/j.cell.2020.08.006 · Cited by 249 · see citing works

Genomic and evolutionary classification of lung cancer in never smokers

Zhang, T., Joubert, P., Ansari‐Pour, N., Wei, Z., Hoang, P. H., Lokanga, R. A., Moye, A. L., Rosenbaum, J., González-Pérez, A., Martínez-Jiménez, F., et al. (2021) · Nature Genetics · doi:10.1038/s41588-021-00920-0 · Cited by 235 · see citing works

Lung cancer in never smokers: The role of different risk factors other than tobacco smoking

Corrales, L., Rosell, R., Cardona, A. F., Martin, C. M., Zatarain-Barrón, Z. L., & Arrieta, O. G. (2020) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2020.102895 · Cited by 226 · see citing works

Targeting SLC3A2 subunit of system XC− is essential for m6A reader YTHDC2 to be an endogenous ferroptosis inducer in lung adenocarcinoma

Ma, L., Zhang, X., Yu, K., Xu, X., Chen, T., Shi, Y. Y., Wang, Y., Qiu, S., Guo, S., Cui, J., et al. (2021) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2021.03.023 · Cited by 184 · see citing works

The landscape of chromothripsis across adult cancer types

Voronina, N., Wong, J., Hübschmann, D., Hlevnjak, M., Uhrig, S., Heilig, C. E., Horak, P., Kreutzfeldt, S., Möck, A., Stenzinger, A., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-16134-7 · Cited by 168 · see citing works

Timing the Initiation of Multiple Myeloma

Rustad, E. H., Yellapantula, V., Leongamornlert, D., Bolli, N., Ledergor, G., Nadeu, F., Angelopoulos, N., Dawson, K. J., Mitchell, T. J., Osborne, R. J., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-15740-9 · Cited by 165 · see citing works

Genomic copy number predicts esophageal cancer years before transformation

Killcoyne, S., Gregson, E., Wedge, D. C., Woodcock, D. J., Eldridge, M. D., de la Rue, R., Miremadi, A., Abbas, S., Blasko, A., Kosmidou, C., et al. (2020) · Nature Medicine · doi:10.1038/s41591-020-1033-y · Cited by 149 · see citing works

Clonal dynamics in early human embryogenesis inferred from somatic mutation

Park, S., Mali, N. M., Kim, R., Choi, J., Lee, J., Lim, J., Park, J. M., Park, J. W., Kim, D., Kim, T., et al. (2021) · Nature · doi:10.1038/s41586-021-03786-8 · Cited by 142 · see citing works

Subclonal reconstruction of tumors by using machine learning and population genetics

Caravagna, G., Heide, T., Williams, M. J., Zapata, L., Nichol, D., Chkhaidze, K., Cross, W. C. H., Cresswell, G. D., Werner, B., Acar, A., et al. (2020) · Nature Genetics · doi:10.1038/s41588-020-0675-5 · Cited by 124 · see citing works

ERα-associated translocations underlie oncogene amplifications in breast cancer

Lee, J. J.-K., Jung, Y. L., Cheong, T.-C., Valle-Inclán, J. E., Chu, C., Gulhan, D., Ljungström, V., Jin, H., Viswanadham, V., Watson, E. V., et al. (2023) · Nature · doi:10.1038/s41586-023-06057-w · Cited by 123 · see citing works

Revealing the Impact of Structural Variants in Multiple Myeloma

Rustad, E. H., Yellapantula, V. D., Głodzik, D., Maclachlan, K. H., Diamond, B. T., Boyle, E. M., Ashby, C., Blaney, P., Gundem, G., Hultcrantz, M. L., et al. (2020) · Blood Cancer Discovery · doi:10.1158/2643-3230.bcd-20-0132 · Cited by 120 · see citing works

Computational analysis of cancer genome sequencing data

Cortés‐Ciriano, I., Gulhan, D., Lee, J. J.-K., Melloni, G. E. M., & Park, P. J. (2021) · Nature Reviews Genetics · doi:10.1038/s41576-021-00431-y · Cited by 116 · see citing works

Non-Small-Cell Lung Cancer Signaling Pathways, Metabolism, and PD-1/PD-L1 Antibodies

Santarpía, M., Aguilar, A., CHAIB-OUKADOUR, I., Cardona, A. F., Fancelli, S., Laguía, F., Bracht, J. W. P., Cao, P., Molina‐Vila, M. Á., Karachaliou, N., et al. (2020) · Cancers · doi:10.3390/cancers12061475 · Cited by 100 · see citing works

Structural Variation in Cancer: Role, Prevalence, and Mechanisms

Cosenza, M. R., Rodríguez–Martín, B., & Korbel, J. O. (2022) · Annual Review of Genomics and Human Genetics · doi:10.1146/annurev-genom-120121-101149 · Cited by 92 · see citing works

Expression and Prognostic Significance of m6A-Related Genes in Lung Adenocarcinoma

Zhang, Y., Liu, X., Liu, L., Li, J., Hu, Q., & Sun, R. (2020) · Medical Science Monitor · doi:10.12659/msm.919644 · Cited by 85 · see citing works

Mitotic clustering of pulverized chromosomes from micronuclei

Lin, Y.-F., Hu, Q., Mazzagatti, A., Valle-Inclán, J. E., Maurais, E. G., Dahiya, R., Guyer, A., Sanders, J. T., Engel, J. L., Nguyen, G., et al. (2023) · Nature · doi:10.1038/s41586-023-05974-0 · Cited by 81 · see citing works

The mutagenic forces shaping the genomes of lung cancer in never smokers

Díaz‐Gay, M., Zhang, T., Hoang, P. H., Leduc, C., Baine, M. K., Travis, W. D., Sholl, L. M., Joubert, P., Khandekar, A., Wei, Z., et al. (2025) · Nature · doi:10.1038/s41586-025-09219-0 · Cited by 81 · see citing works

Histone methyltransferase SETD2: a potential tumor suppressor in solid cancers

Chen, R., Zhao, W., Fang, C., Yang, X., & Ji, M. (2020) · Journal of Cancer · doi:10.7150/jca.38391 · Cited by 80 · see citing works

Proteogenomic analysis of lung adenocarcinoma reveals tumor heterogeneity, survival determinants, and therapeutically relevant pathways

Soltis, A. R., Bateman, N. W., Liu, J., Nguyen, T. M., Franks, T. J., Zhang, X., Dalgard, C. L., Viollet, C., Somiari, S., Yan, C., et al. (2022) · Cell Reports Medicine · doi:10.1016/j.xcrm.2022.100819 · Cited by 76 · see citing works

Boveri and beyond: Chromothripsis and genomic instability from mitotic errors

Mazzagatti, A., Engel, J. L., & Ly, P. (2023) · Molecular Cell · doi:10.1016/j.molcel.2023.11.002 · Cited by 76 · see citing works

The evolving role of liquid biopsy in lung cancer

Malapelle, U., Pisapia, P., Pepe, F., Russo, G., Buono, M., Russo, A., Gomez, J. E., Khorshid, O., Mack, P. C., Rolfo, C. D., et al. (2022) · Lung Cancer · doi:10.1016/j.lungcan.2022.08.004 · Cited by 75 · see citing works

Low-dose CT lung cancer screening in never-smokers and smokers: results of an eight-year observational study

Kakinuma, R., Muramatsu, Y., Asamura, H., WATANABE, S.-I. J., Kusumoto, M., Tsuchida, T., Kaneko, M., Tsuta, K., Maeshima, A. M., Ishii, G., et al. (2020) · Translational Lung Cancer Research · doi:10.21037/tlcr.2020.01.13 · Cited by 74 · see citing works

Unraveling Ewing Sarcoma Tumorigenesis Originating from Patient-Derived Mesenchymal Stem Cells

Solé, A. S., Grossetête, S., Heintzé, M., Babin, L., Zaïdi, S., Revy, P., Renouf, B., Cian, A. D., Giovannangeli, C., Pierre‐Eugène, C., et al. (2021) · Cancer Research · doi:10.1158/0008-5472.can-20-3837 · Cited by 71 · see citing works

Ageing limits stemness and tumorigenesis by reprogramming iron homeostasis

Zhuang, X., Wang, Q., Joost, S., Ferrena, A., Humphreys, D. T., Li, Z., Blum, M., Krause, K., Ding, S., Landais, Y., et al. (2024) · Nature · doi:10.1038/s41586-024-08285-0 · Cited by 70 · see citing works

Widespread somatic L1 retrotransposition in normal colorectal epithelium

Nam, C. H., Youk, J., Kim, J. Y., Lim, J., Park, J. W., Oh, S. A., Lee, H. J., Won, H., Won, H., Lee, D.-S., et al. (2023) · Nature · doi:10.1038/s41586-023-06046-z · Cited by 68 · see citing works

Cellular senescence in cancer: from mechanism paradoxes to precision therapeutics

Feng, T., Xie, F., Lee, L. M.-Y., Lin, Z., Tu, Y., Lyu, Y., Yu, P., Wu, J., Chen, B., Zhang, G., et al. (2025) · Molecular Cancer · doi:10.1186/s12943-025-02419-2 · Cited by 66 · see citing works

METTL3-mediated m6A mRNA modification of FBXW7 suppresses lung adenocarcinoma

Wu, Y., Chang, N., Zhang, Y., Zhang, X., Xu, L., Che, Y., Qiao, T., Wu, B., Zhou, Y., Jiang, J., et al. (2021) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-021-01880-3 · Cited by 62 · see citing works

Scrambling the genome in cancer: causes and consequences of complex chromosome rearrangements

Krupina, K., Goginashvili, A., & Cleveland, D. W. (2023) · Nature Reviews Genetics · doi:10.1038/s41576-023-00663-0 · Cited by 59 · see citing works

Aneuploidy and complex genomic rearrangements in cancer evolution

Baker, T. M., Waise, S., Tarabichi, M., & Loo, P. V. (2024) · Nature Cancer · doi:10.1038/s43018-023-00711-y · Cited by 59 · see citing works

The histone methyltransferase SETD2 modulates oxidative stress to attenuate experimental colitis

Liu, M., Rao, H., Liu, J., Li, X., Feng, W., Gui, L., Tang, H., Xu, J., Gao, W., & Li, L. (2021) · Redox Biology · doi:10.1016/j.redox.2021.102004 · Cited by 55 · see citing works

Chromothripsis-Mediated Small Cell Lung Carcinoma

Rekhtman, N., Tischfield, S. E., Febres‐Aldana, C. A., Lee, J. J.-K., Chang, J. C., Herzberg, B. O., Selenica, P., Woo, H. J., Vanderbilt, C., Yang, S., et al. (2024) · Cancer Discovery · doi:10.1158/2159-8290.cd-24-0286 · Cited by 55 · see citing works

Spatiotemporal dynamics of clonal selection and diversification in normal endometrial epithelium

Yamaguchi, M., Nakaoka, H., Suda, K., Yoshihara, K., Ishiguro, T., Yachida, N., Saito, K., Ueda, H., Sugino, K., Mori, Y., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-28568-2 · Cited by 54 · see citing works

The emerging roles of N6-methyladenosine RNA methylation in human cancers

Shen, H., Lan, Y., Zhao, Y., Shi, Y., Jin, J., & Xie, W. (2020) · Biomarker Research · doi:10.1186/s40364-020-00203-6 · Cited by 54 · see citing works

Long-molecule scars of backup DNA repair in BRCA1- and BRCA2-deficient cancers

Setton, J. S., Hadi, K., Choo, Z.-N., Kuchin, K. S., Tian, H., Paula, A. D. C., Rosiene, J. A., Selenica, P., Behr, J. M., Yao, X., et al. (2023) · Nature · doi:10.1038/s41586-023-06461-2 · Cited by 47 · see citing works

Meiotic nuclear divisions 1 (MND1) fuels cell cycle progression by activating a KLF6/E2F1 positive feedback loop in lung adenocarcinoma

Zhang, Q., Shi, R., Bai, Y., Meng, L., Hu, J., Zhu, H., Liu, T., De, X., Wang, S., Wang, J., et al. (2021) · 癌症：英文版 · doi:10.1002/cac2.12155 · Cited by 46 · see citing works

Tobacco Smoking-Related Mutational Signatures in Classifying Smoking-Associated and Nonsmoking-Associated NSCLC

Ernst, S. M., Mankor, J. M., van Riet, J., von der Thüsen, J. H., Dubbink, H. J., Aerts, J. G. J. V., de Langen, A. J., Smit, E. F., Dingemans, A. C., & Monkhorst, K. (2022) · Journal of Thoracic Oncology · doi:10.1016/j.jtho.2022.11.030 · Cited by 46 · see citing works

Knockdown of microsomal glutathione S-transferase 1 inhibits lung adenocarcinoma cell proliferation and induces apoptosis

Zeng, B., Ge, C., Li, R., Zhang, Z., Fu, Q., Li, Z., Lin, Z., Liu, L., Xue, Y., Xu, Y., et al. (2019) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2019.109562 · Cited by 45 · see citing works

Genomic Characterization of Concurrent Alterations in Non-Small Cell Lung Cancer (NSCLC) Harboring Actionable Mutations

Passaro, A., Attili, I., Rappa, A., Vacirca, D., Ranghiero, A., Fumagalli, C., Guarize, J., Spaggiari, L., de Marinis, F., Barberis, M. C. P., et al. (2021) · Cancers · doi:10.3390/cancers13092172 · Cited by 45 · see citing works

Chromosome structural variation in tumorigenesis: mechanisms of formation and carcinogenesis

Wang, W., Li, L., & Cui, J. (2020) · Epigenetics & Chromatin · doi:10.1186/s13072-020-00371-7 · Cited by 44 · see citing works

Quantitative and qualitative mutational impact of ionizing radiation on normal cells

Youk, J., Kwon, H. W., Lim, J., Kim, E., Kim, T., Kim, R., Park, S., Yi, K., Nam, C. H., Jeon, S., et al. (2024) · Cell Genomics · doi:10.1016/j.xgen.2024.100499 · Cited by 43 · see citing works

Emerging oncogenic fusions other than ALK, ROS1, RET, and NTRK in NSCLC and the role of fusions as resistance mechanisms to targeted therapy

Suda, K., & Mitsudomi, T. (2020) · Translational Lung Cancer Research · doi:10.21037/tlcr-20-186 · Cited by 42 · see citing works

Molecular characteristics and clinical outcomes of complex ALK rearrangements identified by next-generation sequencing in non-small cell lung cancers

Xia, P., Zhang, L., Li, P., Liu, E., Li, W., Zhang, J., Li, H., Su, X., & Jiang, G. (2021) · Journal of Translational Medicine · doi:10.1186/s12967-021-02982-4 · Cited by 41 · see citing works

A signature of estimate-stromal-immune score-based genes associated with the prognosis of lung adenocarcinoma

Ma, Q., Chen, Y., Xiao, F., Hao, Y., Song, Z., Zhang, J., Okuda, K., Um, S., Silva, M., Shimada, Y., et al. (2021) · Translational Lung Cancer Research · doi:10.21037/tlcr-21-223 · Cited by 41 · see citing works

Gene Duplication and Gene Fusion Are Important Drivers of Tumourigenesis during Cancer Evolution

Glenfield, C., & Innan, H. (2021) · Genes · doi:10.3390/genes12091376 · Cited by 41 · see citing works

Characterization of novel CTNNB1 mutation in Craniopharyngioma by whole-genome sequencing

He, J., Zeng, Z., Wang, Y., Deng, J., Tang, X., Liu, F., Huang, J., Chen, H., Liang, R., Zan, X., et al. (2021) · Molecular Cancer · doi:10.1186/s12943-021-01468-7 · Cited by 40 · see citing works

Tracing Lung Cancer Risk Factors Through Mutational Signatures in Never-Smokers

Landi, M. T., Synnott, N. C., Rosenbaum, J., Zhang, T., Zhu, B., Shi, J., Wei, Z., Kebede, M., Sang, J., Choi, J., et al. (2020) · American Journal of Epidemiology · doi:10.1093/aje/kwaa234 · Cited by 40 · see citing works

Most large structural variants in cancer genomes can be detected without long reads

Choo, Z.-N., Behr, J. M., Deshpande, A. S., Hadi, K., Yao, X., Tian, H., Takai, K., Zakusilo, G., Rosiene, J. A., Paula, A. D. C., et al. (2023) · Nature Genetics · doi:10.1038/s41588-023-01540-6 · Cited by 39 · see citing works

Chromothripsis as a pathogenic driver of multiple myeloma

Maura, F., Boyle, E. M., Rustad, E. H., Ashby, C., Kaminetzky, D., Bruno, B., Braunstein, M. J., Bauer, M., Blaney, P., Wang, Y., et al. (2021) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2021.04.014 · Cited by 39 · see citing works

Weight-bearing activity impairs nuclear membrane and genome integrity via YAP activation in plantar melanoma

Seo, J., Kim, H., Min, K. I., Kim, C., Kwon, Y., Zheng, Z., Kim, Y., Park, H., Ju, Y. S., Roh, M. R., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-29925-x · Cited by 39 · see citing works

Targeted in silico characterization of fusion transcripts in tumor and normal tissues via FusionInspector

Haas, B. J., Dobin, A., Ghandi, M., Arsdale, A. V., Tickle, T. L., Robinson, J., Gillani, R., Kasif, S., & Regev, A. (2023) · Cell Reports Methods · doi:10.1016/j.crmeth.2023.100467 · Cited by 38 · see citing works

Mutated circulating tumor DNA as a liquid biopsy in lung cancer detection and treatment

Filipska, M., & Rosell, R. (2021) · Molecular Oncology · doi:10.1002/1878-0261.12983 · Cited by 38 · see citing works

Comprehensive genomic profile of Chinese lung cancer patients and mutation characteristics of individuals resistant to icotinib/gefitinib

Shang, Y., Li, X., Liu, W., Shi, X., Yuan, S. H., Huo, R., Fang, G., Han, X., Zhang, J., Wang, K., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-76791-y · Cited by 36 · see citing works

Advances in Lung Cancer Driver Genes Associated With Brain Metastasis

Kang, Y., Jin, Y. T., Li, Q., & Yuan, X. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2020.606300 · Cited by 36 · see citing works

SETD2 deficiency accelerates sphingomyelin accumulation and promotes the development of renal cancer

Rao, H., Liu, C., Wang, A., Ma, C., Xu, Y., Ye, T., Su, W., Zhou, P., Gao, W., Li, L., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-43378-w · Cited by 35 · see citing works

Chromosomal rearrangements and their neoantigenic potential in mesothelioma

Mansfield, A. S., Peikert, T., & Vasmatzis, G. (2020) · Translational Lung Cancer Research · doi:10.21037/tlcr.2019.11.12 · Cited by 35 · see citing works

A whole-genome reference panel of 14,393 individuals for East Asian populations accelerates discovery of rare functional variants

Choi, J., Kim, S., Kim, J., Son, H., Yoo, S., Kim, C.-U., Park, Y. J., Moon, S., Cha, B., Jeon, M. C., et al. (2023) · Science Advances · doi:10.1126/sciadv.adg6319 · Cited by 34 · see citing works

Mechanistic origins of diverse genome rearrangements in cancer

Dahiya, R., Hu, Q., & Ly, P. (2021) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2021.03.003 · Cited by 34 · see citing works

A genetic basis for sex differences in Xp11 translocation renal cell carcinoma

Achom, M., Sadagopan, A., Bao, C., McBride, F., Li, J., Konda, P., Tourdot, R. W., Xu, Q., Nakhoul, M., Gallant, D. S., et al. (2024) · Cell · doi:10.1016/j.cell.2024.07.038 · Cited by 33 · see citing works

Chromothripsis in Human Breast Cancer

Bolkestein, M., Wong, J., Thewes, V., Körber, V., Hlevnjak, M., Elgaafary, S., Schulze, M., Kommoss, F. K. F., Sinn, H., Anzeneder, T., et al. (2020) · Cancer Research · doi:10.1158/0008-5472.can-20-1920 · Cited by 33 · see citing works

Molecular Characterization and Therapeutic Targeting of Colorectal Cancers Harboring Receptor Tyrosine Kinase Fusions

Singh, H., Li, Y. Y., Spurr, L. F., Shinagare, A. B., Abhyankar, R., Reilly, E., Brais, L. K., Nag, A., Ducar, M. D., Thorner, A. R., et al. (2021) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-20-4073 · Cited by 33 · see citing works

Management of Ground-Glass Nodules: When and How to Operate?

Kim, Y. T. (2022) · Cancers · doi:10.3390/cancers14030715 · Cited by 32 · see citing works

Chromothripsis in cancer

Simovic-Lorenz, M., & Ernst, A. (2024) · Nature reviews. Cancer · doi:10.1038/s41568-024-00769-5 · Cited by 31 · see citing works

Phasing analysis of lung cancer genomes using a long read sequencer

Sakamoto, Y., Miyake, S., Oka, M., Kanai, A., Kawai, Y., Nagasawa, S., Shiraishi, Y., Tokunaga, K., Kohno, T., Seki, M., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-31133-6 · Cited by 31 · see citing works

Whole-genome characterization of lung adenocarcinomas lacking alterations in the RTK/RAS/RAF pathway

Carrot‐Zhang, J., Yao, X., Devarakonda, S. H. K., Deshpande, A. S., Damrauer, J. S., Silva, T. C., Wong, C. K., Choi, H. Y., Felau, I., Robertson, A. G., et al. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.108707 · Cited by 30 · see citing works

Acquired Resistance to Third-Generation EGFR Tyrosine Kinase Inhibitors in Patients With De Novo EGFRT790M-Mutant NSCLC

Park, H.-R., Kim, T. M., Lee, Y., Kim, S., Park, S., Ju, Y. S., Kim, M., Keam, B., Jeon, Y. K., Kim, D., et al. (2021) · Journal of Thoracic Oncology · doi:10.1016/j.jtho.2021.06.013 · Cited by 30 · see citing works

Genomic characteristics of invasive mucinous adenocarcinoma of the lung with multiple pulmonary sites of involvement

Kim, M., Hwang, J., Kim, K., Hwang, S., Lee, H., Jung, J. Y., Lee, J. G., Cha, Y. J., & Shim, H. S. (2021) · Modern Pathology · doi:10.1038/s41379-021-00872-0 · Cited by 30 · see citing works

Diagnostic Utility of Gene Fusion Panel to Detect Gene Fusions in Fresh and Formalin-Fixed, Paraffin-Embedded Cancer Specimens

Haley, L. M., Parimi, V., Jiang, L., Pallavajjala, A., Hardy, M., Yonescu, R., Morsberger, L. A., Stinnett, V., Long, P., Zou, Y. S., et al. (2021) · Journal of Molecular Diagnostics · doi:10.1016/j.jmoldx.2021.07.015 · Cited by 30 · see citing works

Resistance to anaplastic lymphoma kinase inhibitors: knowing the enemy is half the battle won

Tabbò, F., Reale, M. L., Bironzo, P., & Scagliotti, G. V. (2020) · Translational Lung Cancer Research · doi:10.21037/tlcr-20-372 · Cited by 29 · see citing works

METTL3 exerts synergistic effects on m6A methylation and histone modification to regulate the function of VGF in lung adenocarcinoma

Shi, K., Sa, R., Dou, L., Wu, Y., Dong, Z., Fu, X., & Yu, H. (2023) · Clinical Epigenetics · doi:10.1186/s13148-023-01568-9 · Cited by 29 · see citing works

Clinical application of whole-genome sequencing of solid tumors for precision oncology

Kim, R., Kim, S., Oh, B. B.-L., Yu, W. S., Kim, C. W., Hur, H., Son, S., Yang, M. J., Cho, D. S., Ha, T., et al. (2024) · Experimental & Molecular Medicine · doi:10.1038/s12276-024-01288-x · Cited by 28 · see citing works

Molecular charcterization of lung adenocarcinoma combining whole exome sequencing, copy number analysis and gene expression profiling

Testa, U., Pelosi, E., & Castelli, G. (2021) · Expert Review of Molecular Diagnostics · doi:10.1080/14737159.2022.2017774 · Cited by 28 · see citing works

Unravelling the tumour genome: The evolutionary and clinical impacts of structural variants in tumourigenesis

Hamdan, A., & Ewing, A. (2022) · The Journal of Pathology · doi:10.1002/path.5901 · Cited by 29 · see citing works

Targeted Therapy for Non-Small Cell Lung Cancer

Noor, Z. S., Cummings, A. L., Johnson, M. M., Spiegel, M. L., & Goldman, J. W. (2020) · Seminars in Respiratory and Critical Care Medicine · doi:10.1055/s-0039-1700994 · Cited by 27 · see citing works

STRN-ALK Fusion in Lung Adenocarcinoma with Excellent Response Upon Alectinib Treatment: A Case Report and Literature Review

Su, C., Jiang, Y., Jiang, W. I., Wang, H., Liu, S., Shao, Y. W., Zhao, W., Ning, R., & Yu, Q. (2020) · OncoTargets and Therapy · doi:10.2147/ott.s282933 · Cited by 26 · see citing works

Multilevel Regulation of β-Catenin Activity by SETD2 Suppresses the Transition from Polycystic Kidney Disease to Clear Cell Renal Cell Carcinoma

Rao, H., Li, X., Liu, M., Liu, J., Feng, W., Tang, H., Xu, J., Gao, W., & Li, L. (2021) · Cancer Research · doi:10.1158/0008-5472.can-20-3960 · Cited by 25 · see citing works

RNA-binding motif protein 10 represses tumor progression through the Wnt/β- catenin pathway in lung adenocarcinoma

Cao, Y., Geng, J., Wang, X., Meng, Q., Xu, S., Lang, Y., Zhou, Y., Qi, L., Wang, Z., Wei, Z., et al. (2021) · International Journal of Biological Sciences · doi:10.7150/ijbs.63598 · Cited by 25 · see citing works

Novel molecular targets for the treatment of lung cancer

Rosell, R., Karachaliou, N., & Arrieta, O. G. (2019) · Current Opinion in Oncology · doi:10.1097/cco.0000000000000590 · Cited by 24 · see citing works

Whole-genome characterization of lung adenocarcinomas lacking alterations in the RTK/RAS/RAF pathway

Carrot‐Zhang, J., Yao, X., Devarakonda, S. H. K., Deshpande, A. S., Damrauer, J. S., Silva, T. C., Wong, C. K., Choi, H. Y., Felau, I., Robertson, A. G., et al. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.108784 · Cited by 24 · see citing works

Mutational landscape of multiple primary lung cancers and its correlation with non-intrinsic risk factors

Izumi, M., Oyanagi, J., Sawa, K., Fukui, M., Ogawa, K., Matsumoto, Y., Tani, Y., Suzumura, T., Watanabe, T., Kaneda, H., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-83609-y · Cited by 24 · see citing works

Cancer Genomic Rearrangements and Copy Number Alterations from Errors in Cell Division

Zhang, C., & Pellman, D. S. (2022) · Annual Review of Cancer Biology · doi:10.1146/annurev-cancerbio-070620-094029 · Cited by 23 · see citing works

Multi-Omics Integrative Analysis of Lung Adenocarcinoma: An in silico Profiling for Precise Medicine

Ruan, X., Ye, Y., Cheng, W., Xu, L., Huang, M., Chen, Y., Zhu, J., Lu, X., & Yan, F. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2022.894338 · Cited by 22 · see citing works

Epidemiological characteristics and risk factors of lung adenocarcinoma: A retrospective observational study from North China

Li, D., Shi, J. F., Dong, X., Liang, D., Jin, J., & He, Y. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.892571 · Cited by 22 · see citing works

Unraveling the Impact of Intratumoral Heterogeneity on EGFR Tyrosine Kinase Inhibitor Resistance in EGFR-Mutated NSCLC

Kobayashi, K., & Tan, A. C. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24044126 · Cited by 22 · see citing works

Prognostic Implication and Immunological Role of PSMD2 in Lung Adenocarcinoma

Zhao, H., & Lu, G. (2022) · Frontiers in Genetics · doi:10.3389/fgene.2022.905581 · Cited by 22 · see citing works

BDH1‐mediated LRRC31 regulation dependent on histone lysine β‐hydroxybutyrylation to promote lung adenocarcinoma progression

Huang, J., Liang, L., Jiang, S., Liu, Y., He, H., Sun, X., Li, Y., Xie, L., Tao, Y., Li, C., et al. (2023) · MedComm · doi:10.1002/mco2.449 · Cited by 21 · see citing works

The genomic landscape of lung cancer in never-smokers from the Women’s Health Initiative

Moorthi, S., Paguirigan, A. L., Itagi, P., Ko, M., Pettinger, M. B., Hoge, A. C. H., Nag, A., Patel, N. A., Wu, F., Sather, C. L., et al. (2024) · JCI Insight · doi:10.1172/jci.insight.174643 · Cited by 20 · see citing works

The Effect of GLUT1 on the Survival Rate and Immune Cell Infiltration of Lung Adenocarcinoma and Squamous Cell Carcinoma: A Meta and Bioinformatics Analysis

Zhang, G., Dong, R., Kong, D., Liu, B., Zha, Y., & Luo, M. (2021) · Anti-Cancer Agents in Medicinal Chemistry · doi:10.2174/1871520621666210708115406 · Cited by 20 · see citing works

Multiple primary lung cancer: Updates and perspectives

Wang, Z., Zhang, Q., Wang, C., Herth, F. J. F., Guo, Z., & Zhang, X. (2024) · International Journal of Cancer · doi:10.1002/ijc.34994 · Cited by 19 · see citing works

Advances in deubiquitinating enzymes in lung adenocarcinoma

Zhou, X., Li, R., Liu, X., & Qu, Y.-Q. (2021) · Journal of Cancer · doi:10.7150/jca.56532 · Cited by 19 · see citing works

Efficacy, safety and pharmacokinetics of Unecritinib (TQ-B3101) for patients with ROS1 positive advanced non-small cell lung cancer: a Phase I/II Trial

Lü, S., Pan, H., Wu, L., Yao, Y., He, J., Wang, Y., Wang, X., Fang, Y., Zhou, Z. X., Wang, X., et al. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01454-z · Cited by 19 · see citing works

Whole-genome landscapes of 1,364 breast cancers

Kim, R., Yu, J., Lim, J., Oh, B., Nam, S. J., Kim, S. W., Lee, J. E., Chae, B. J., Kim, J., Park, G. E., et al. (2025) · Nature · doi:10.1038/s41586-025-09812-3 · Cited by 18 · see citing works

Spatial and clonality-resolved 3D cancer genome alterations reveal enhancer-hijacking as a potential prognostic marker for colorectal cancer

Kim, K., Kim, M., Lee, A., Song, S., Kang, J., Eom, J., Kang, G. H., Bae, J. M., Min, S., Kim, Y. S., et al. (2023) · Cell Reports · doi:10.1016/j.celrep.2023.112778 · Cited by 17 · see citing works

FAM201A knockdown inhibits proliferation and invasion of lung adenocarcinoma cells by regulating miR‐7515/GLO1 axis

Huang, J., Yu, Q., Zhou, Y., Chu, Y., Jiang, F., & Wang, Q. (2021) · Journal of Cellular Physiology · doi:10.1002/jcp.30250 · Cited by 17 · see citing works

Abstract 2055: Prevalent focal amplification of oncogene in lung adenocarcinomas without canonical driver alterations

Park, S., Lim, J., Yi, K., Yi, B., Kim, R., Koo, J., Na, K. J., Park, S., Park, I. K., Kang, C. H., et al. (2023) · Cancer Research · doi:10.1158/1538-7445.am2023-2055

MA 06.12 Genomic Rearrangements of Lung Adenocarcinomas with Fusion Driver Gene

Park, S., Lee, J., Lee, J. S. H., Yi, K., Kang, K. H., Kim, Y. T., & Ju, Y. S. (2017) · Journal of Thoracic Oncology · doi:10.1016/j.jtho.2017.09.499

Development of Lung Adenocarcinomas with Exclusive Dependence on Oncogene Fusions

Saito, M., Shimada, Y., Shiraishi, K., Sakamoto, H., Tsuta, K., Totsuka, H., Chiku, S., Ichikawa, H., Kato, M., WATANABE, S.-I. I., et al. (2015) · Cancer Research · doi:10.1158/0008-5472.can-14-3282 · Cited by 43 · see citing works

P3.02-035 Mutational Signatures and Their Association with Clinicopathological Features in Lung Adenocarcinoma of Smokers

Honda, T., Shiraishi, K., Sakashita, H., Masai, K., Kobayashi, M., Mimaki, S., Motoi, N., Tsuchihara, K., Tsuta, K., Okubo, K., et al. (2017) · Journal of Thoracic Oncology · doi:10.1016/j.jtho.2017.09.1565

Deciphering lung adenocarcinoma evolution and the role of LINE-1 retrotranspositionPreprint

Zhang, T., Zhao, W., Wirth, C., Díaz‐Gay, M., Yin, J., Cecati, M., Marchegiani, F., Hoang, P. H., Leduc, C., Baine, M. K., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.03.14.643063 · Cited by 7 · see citing works